Tooru (LSE:TOO) said its operating subsidiaries continued to perform strongly through 2025 and into the early part of 2026, generating solid EBITDA alongside average monthly gross revenue of approximately £1 million and EBITDA of around £150,000. Management indicated that growth is expected to continue as the company’s brands expand their market positions and benefit from recent investment initiatives.
OAF expansion and Pulsin recovery support growth strategy
The company highlighted encouraging progress across its portfolio, particularly at OAF, which has secured a launch with Asda, broadened its product range within Tesco and increased brand visibility through participation in industry trade events. Management believes OAF is becoming an important near-term growth contributor within the group.
Pulsin has also returned to growth following product range optimisation, additional capital investment and the introduction of a new contract manufacturing arrangement, which management said has contributed to improved profit margins. Alongside this, Tooru continues to explore the potential acquisition of Mylky as part of efforts to increase scale and earnings within the branded wellness sector.
The company said these developments support its ambition to strengthen its position in the health and wellness market despite continued caution among investors towards growth-oriented businesses.
More about Tooru plc
Tooru plc is an AIM-listed business operating in the branded health and wellness sector. Its portfolio includes brands such as Juvela, OAF and Pulsin, with products distributed through both specialist retailers and major UK supermarket chains. The group focuses on expanding mainstream retail access for health-focused food and wellness products across the UK market.
Leave a Reply